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Crohn’s
  disease
  is
  a
  chronic
  inﬂammatory
  condition
  largely
  affecting
  the
  terminal
  ileum
  and
  large
  bowel.
A
  contributing
  cause
  is
  the
  failure
  of
  an
  adequate
  acute
  inﬂammatory
  response
  as
  a
  result
  of
  impaired
secretion
  of
  pro-inﬂammatory
  cytokines
  by
  macrophages.
  This
  defective
  secretion
  arises
  from
  aberrant
vesicle
  trafﬁcking,
  misdirecting
  the
  cytokines
  to
  lysosomal
  degradation.
  Aberrant
  intestinal
  permeabil-
ity
  is
  also
  well-established
  in
  Crohn’s
  disease.
  Both
  the
  disordered
  vesicle
  trafﬁcking
  and
  increased
bowel
  permeability
  could
  result
  from
  abnormal
  lipid
  composition.
  We
  thus
  measured
  the
  sphingo-
and
  phospholipid
  composition
  of
  macrophages,
  using
  mass
  spectrometry
  and
  stable
  isotope
  labelling
approaches.
  Stimulation
  of
  macrophages
  with
  heat-killed
  Escherichia
  coli
  resulted
  in
  three
  main
  changes;
a
  signiﬁcant
  reduction
  in
  the
  amount
  of
  individual
  ceramide
  species,
  an
  altered
  composition
  of
  phos-
phatidylcholine,
  and
  an
  increased
  rate
  of
  phosphatidylcholine
  synthesis
  in
  macrophages.
  These
  changes
were
  observed
  in
  macrophages
  from
  both
  healthy
  control
  individuals
  and
  patients
  with
  Crohn’s
  disease.
The
  only
  difference
  detected
  between
  control
  and
  Crohn’s
  disease
  macrophages
  was
  a
  reduced
  propor-
tion
 of
 newly-synthesised
 phosphatidylinositol
 16:0/18:1
 over
 a
 deﬁned
 time
 period.
 Shotgun
 lipidomics
analysis
  of
  macroscopically
  non-inﬂamed
  ileal
  biopsies
  showed
  a
  signiﬁcant
  decrease
  in
  this
  same
  lipid
species
  with
  overall
  preservation
  of
  sphingolipid,
  phospholipid
  and
  cholesterol
  composition.
Crown Copyright ©
   2012 Published by Elsevier Ltd. All rights reserved.
1.
  Introduction
A
  number
  of
  physiological
  processes
  have
  been
  shown
  to
  be
disturbed
  in
  Crohn’s
  disease
  (CD).
  A
  recently
  described
  manifes-
tation
  is
  the
  failure
  of
  acute
  inﬂammation,
  resulting
  in
  impaired
clearance
  of
  bacteria
  from
  the
  tissues.
  This
  is
  due
  to
  mistarget-
ing
  of
  pro-inﬂammatory
  mediators
  to
  lysosomal
  degradation
  in
macrophages
  as
  a
  result
  of
  aberrant
  vesicle
  trafﬁcking
  (Smith
  et
  al.,
Abbreviations:
  CCT,
  Phosphocholine
  cytidylyltransferase;
  CD,
  Crohn’s
  disease;
GWAS,
  Genome-wide
  association
  study;
  HC,
  Healthy
  control;
  HkEc,
  Heat-killed
Escherichia
  coli;
  PA,
  Phosphatidic
  acid;
  PC,
  Phosphatidylcholine;
  PI,
  Phosphatidyli-
nositol;
  PS,
  Phosphatidylserine;
  TNF,
  Tumor
  necrosis
  factor.
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 Autophagy
 (Cooney
 et
 al.,
 2010)
 and
 apoptosis
 (Palmer
 et
 al.,
2009)
  have
  also
  been
  shown
  to
  be
  abnormal
  in
  CD,
  and
  intestinal
permeability
  is
  increased
  in
  this
  condition
  (Hollander
  et
  al.,
  1986).
Sphingolipids
  and
  phospholipids
  play
  key
  roles
  in
  the
  modula-
tion
  of
  inﬂammation
  and
  immunity
  (El
  et
  al.,
  2006).
  Ceramide
  and
ceramide-1-phosphate
  act
  to
  reduce
  tumor
  necrosis
  factor
  (TNF)
release
  (Jozefowski
  et
  al.,
  2010),
  most
  likely
  via
  post-translational
regulation
  of
  TNF
  and
  modulation
  of
  TNF
  converting
  enzyme
  activ-
ity
 (Rozenova
 et
 al.,
 2010).
 Furthermore,
 ceramides
 have
 important
roles
  in
  the
  control
  of
  autophagy,
  a
  process
  strongly
  implicated
  in
the
  pathogenesis
  of
  CD
  (Barrett
  et
  al.,
  2008).
  Addition
  of
  exoge-
nous
 ceramide
 induces
 autophagy
 (Scarlatti
 et
 al.,
 2004),
 which
 may
relate
  to
  effects
  on
  signalling
  networks
  or
  changes
  in
  the
  biophys-
ical
  membrane
  properties
  (Zheng
  et
  al.,
  2006).
Phosphatidylcholine
  (PC)
  is
  an
  important
  structural
  component
of
  all
  cell
  membranes,
  including
  intracellular
  vesicles
  (Howe
  and
1357-2725/$
  –
  see
  front
  matter.
  Crown Copyright ©
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McMaster,
  2001).
  In
  macrophages,
  the
  generation
  of
  PC
  may
  play
a
  role
  in
  differentiation
  (Ecker
  et
  al.,
  2010)
  and
  pro-inﬂammatory
cytokine
  release
  (Tian
  et
  al.,
  2008).
  Murine
  macrophages
  deﬁcient
in
  phosphocholine
  cytidylyltransferase
  (CCT-)
  secrete
  reduced
levels
  of
  TNF
  and
  IL-6
  in
  response
  to
  lipopolysaccharide
  (LPS)
  stim-
ulation,
  as
  a
  result
  of
  abnormal
  post-translational
  processing
  and
retention
  of
  these
  molecules
  in
  the
  Golgi
  apparatus,
  similar
  to
  the
situation
  observed
  in
  CD
  macrophages.
Phosphatidylinositol
  (PI)
  is
  an
  important
  structural
  phospho-
lipid,
  and
  also
  a
  substrate
  for
  lipid
  kinases
  and
  phosphatases,
which
  can
  generate
  phosphoinositide
  derivatives
  (PIPs).
  PIPs
  are
critical
  second
  messenger
  molecules
  in
  pathways
  involved
  in
  the
control
  of
  cytoskeletal
  re-organisation
  and
  membrane
  trafﬁcking
(Odorizzi
  et
  al.,
  2000).
  PI
  3-kinase,
  an
  enzyme
  that
  converts
  PI
species
  to
  phosphatidylinositol-3,4,5-trisphosphate,
  is
  important
for
  TNF
  trafﬁcking
  from
  the
  Golgi
  apparatus
  to
  the
  plasma
  mem-
brane
  in
  macrophages
  (Low
  et
  al.,
  2010).
Various
  studies
  have
  suggested
  alterations
  in
  lipid
  metabolism
in
  CD.
  Positive
  correlations
  exist
  between
  dietary
  fat
  consump-
tion
  and
  the
  development
  of
  CD
  (Amre
  et
  al.,
  2007;
  Shoda
  et
  al.,
1996).
  Genome-wide
  association
  studies
  (GWAS)
  have
  identi-
ﬁed
  CD-associated
  variants
  in
  loci
  containing
  genes
  related
  to
lipid
  metabolism.
  Speciﬁcally,
  a
  locus
  containing
  the
  ORMDL3
gene
  confers
  susceptibility
  to
  CD
  (Barrett
  et
  al.,
  2008).
  ORM
genes
  are
  involved
  in
  sphingolipid
  homeostasis;
  the
  ORM
  proteins
encoded
  by
  these
  genes
  act
  as
  negative
  regulators
  of
  sphingolipid
metabolism
  (Breslow
  et
  al.,
  2010).
  Furthermore,
  the
  recent
  GWAS
meta-analysis
  identiﬁed
  a
  CD-associated
  SNP
  in
  close
  proximity
  to
FADS1
  (Franke
  et
  al.,
  2010),
  which
  encodes
  the
  fatty
  acid
  desat-
urase
  1
  enzyme.
  Genetic
  variation
  in
  this
  gene
  is
  associated
  with
alterations
  in
  the
  fatty
  acid
  composition
  in
  serum
  phospholipids
(Schaeffer
  et
  al.,
  2006).
Studies
  conducted
  on
  biological
  samples
  have
  demonstrated
decreased
  membrane
  ﬂuidity
  in
  erythrocytes
  from
  CD
  patients,
with
  concomitant
  increases
  in
  sphingomyelin
  and
  reductions
  in
phosphatidylcholine
  and
  polyunsaturated
  acyl
  chains
  of
  phospho-
lipid
  (Aozaki,
  1989).
  Increased
  concentrations
  of
  lactosylceramide
have
  been
  reported
  in
  bowel
  biopsies
  from
  CD
  patients
  (Stevens
et
  al.,
  1988),
  although
  it
  is
  possible
  that
  these
  changes
  were
  sec-
ondary
  to
  inﬂammation.
  There
  is
  somewhat
  conﬂicting
  evidence
describing
 fatty
 acid
 abnormalities
 in
 CD,
 including
 in
 plasma
 phos-
pholipids
  (Esteve-Comas
  et
  al.,
  1992,
  1993;
  Geerling
  et
  al.,
  1999)
and
  PBMCs
  (Trebble
  et
  al.,
  2004).
  Lipids
  from
  adipose
  and
  lym-
phoid
  tissues
  contain
  more
  saturated
  but
  fewer
  polyunsaturated
fatty
  acids,
  with
  preferential
  depletion
  of
  n-6
  polyunsaturates
  in
lymphoid
  tissue
  (Westcott
  et
  al.,
  2005).
Macrophage
  phospholipid
  and
  sphingolipid
  composition
  have
not
  been
  previously
  investigated
  in
  CD.
  Given
  the
  possibility
that
  macrophage
  sphingolipid
  or
  phospholipid
  composition
  could
underlie
  the
  defective
  cytokine
  secretion
  from
  macrophages
  that
is
  observed
  in
  CD,
  these
  molecules
  were
  quantiﬁed
  using
  high
performance
  liquid
  chromatography
  tandem
  mass
  spectrometry
(HPLC-MS).
  Phospholipid
  composition
  and
  dynamics
  were
  inves-
tigated
  using
  stable
  isotope
  labelling
  and
  electrospray
  ionisation
mass
  spectrometry
  (ESI-MS).
2.
  Materials
  and
  methods
2.1.
  Subject
  recruitment
  and
  selection
Patients
  from
  University
  College
  London
  Hospitals
  Foundation
NHS
  Trust
  fulﬁlled
  criteria
  for
  the
  diagnosis
  of
  CD
  (Lennard-Jones,
1989).
  All
  patients
  in
  the
  macrophage
  studies
  were
  between
  18
and
  75
  years
  of
  age
  and
  had
  quiescent
  disease,
  as
  determined
by
  the
  Harvey-Bradshaw
  disease
  activity
  index
  of
  <3
  (Harvey
  and
Table
  1
Demographics
  of
  patients.
  Demographics
  of
  patients
  and
  healthy
  controls
  (HC)
included
  in
  (A)
  sphingolipid
  study,
  (B)
  phospholipid
  studies
  and
  (C)
  shotgun
lipidomics
  study.
A
Unstimulated HkEc
  stimulated
HC
  CD
  HC
  CD
Number 7 8 7 12
M:F 5:2
  4:4
  5:2
  6:6
Mean
  age 44.1
  36.2
  44.1
  39.7
Age
  standard
  deviation
  15.6
  12.9
  15.6
  14.8
Age
  range
  23–63
  19–63
  23–63
  19–65
Smokers
  0
  0
  0
  1
Treatment
No
  medication 2 4
5-ASA 6
  8
B
Unstimulated
  HkEc
  stimulated
HC
  CD
  HC
  CD
Number
  10
  13
  7
  8
M:F
  5:5
  6:7
  5:2
  4:4
Mean
  age 33.5
  36.5
  34.8
  35.1
Age
  standard
  deviation
  9.2
  13.7
  10.4
  11.6
Age
  range 22–55
  23–70
  22–55
  23–61
Smokers
  1
  1
  0
  1
Treatment
No
  medication
  6
  3
5-ASA
  7
  5
Mean
  BMI 23.7
  23.3
  23.3
  23.3
BMI
  standard
  deviation
  3.5
  3.0
  3.8
  3.7
BMI
  range 17.8–30.5
  19.4–29.4
  17.8–30.5
  19.4–29.4
C
HC
  CD
Number
  5
  5
M:F 1:4
  3:2
Mean
  age
  40.0
  33.1
Age
  standard
  deviation
  17.8
  10.1
Age
  range 21–54 20–46
Smokers
  0
  0
Treatment
No
  medication
  3
5-ASA
  1
Methotrexate
  1
Previous
  resection
  2
Active
  disease
  2
Bradshaw,
  1980),
  and
  were
  receiving
  either
  no
  treatment
  or
  a
  sta-
ble
 dose
 (for
 the
 preceding
 3
 months)
 of
 5-aminosalicylates
 (5-ASA)
alone.
 Healthy
 volunteers
 were
 between
 18
 and
 75
 years
 of
 age
 and
were
  not
  receiving
  immunosuppressant
  medication.
  Demograph-
ics
  of
  patients
  included
  in
  these
  studies
  are
  shown
  (Table
  1).
For
  shotgun
  lipidomics
  investigations,
  ileal
  biopsies
  were
obtained
  from
  CD
  patients
  (n
 =
 5)
  and
  control
  individuals
  (n
 =
 5).
Two
  of
  the
  patients
  had
  macroscopic
  and
  microscopic
  evidence
  of
active
  disease;
  the
  remaining
  patients
  had
  macroscopic
  and
  his-
tologic
  features
  consistent
  with
  quiescent
  disease.
  Three
  patients
were
 receiving
 no
 treatment,
 one
 was
 receiving
 5-aminosalicylates
and
  one
  was
  receiving
  methotrexate.
  Two
  patients
  had
  previous
ileal
  resections;
  in
  these
  cases
  biopsies
  from
  the
  neoterminal
  ileum
were
  obtained.
  In
  all
  cases
  biopsies
  were
  taken
  from
  macroscopi-
cally
  non-inﬂamed
  bowel.
Ethical
  approval
  was
  obtained
  from
  the
  Joint
  UCL/UCLH
  Com-
mittees
 on
 the
 Ethics
 of
 Human
 Research
 (project
 number
 02/0324).
No
  subject
  was
  studied
  more
  than
  once
  in
  each
  of
  the
  different
  sets
of
  experiments.G.W.
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2.2.
  Primary
  macrophage
  isolation,
  culture
  and
  stimulation
Peripheral
  blood
  mononuclear
  cells
  were
  isolated
  from
  venous
blood
  samples
  as
  previously
  described
  (Smith
  et
  al.,
  2009).
  After
5
  days
  of
  culture,
  cells
  were
  harvested,
  resuspended
  in
  X-Vivo-15
medium
  (Cambrex,
  MD,
  USA)
  and
  plated
  into
  BD
  FalconTM culture
plates.
2.3.
  Sphingolipid
  analysis
  of
  cultured
  macrophages
Monocyte-derived
  macrophages
  were
  stimulated
  for
  4
 h
  with
heat-killed
  Escherichia
  coli
  (HkEc),
  as
  previously
  described
  (Smith
et
 al.,
 2009).
 Cells
 were
 harvested
 in
 PBS,
 resuspended
 in
 200
 l
 PBS
and
  sonicated.
  10
 l
  aliquots
  were
  obtained
  for
  protein
  determina-
tion.
The
 ceramide
 content
 of
 the
 solution
 remaining
 was
 determined
using
  HPLC-MS
  by
  established
  methods
  (Bielawski
  et
  al.,
  2009).
Samples
  were
  quantiﬁed
  by
  HPLC-MS
  on
  a
  Thermo
  Finnigan
  TSQ
7000
  triple
  quadrupole
  mass
  spectrometer
  operating
  in
  a
  Mul-
tiple
  Reaction
  Monitoring
  positive
  ionisation
  mode.
  Sphingolipid
concentrations
  were
  normalised
  in
  relation
  to
  total
  protein
  con-
centrations.
2.4.
  BCA
  assay
The
  protein
  content
  of
  samples
  was
  determined
  using
  the
  bicin-
choninic
 acid
 (BCA)
 assay
 (Thermo
 Fisher
 Scientiﬁc
 Inc)
 with
 bovine
serum
  albumin
  as
  standard.
2.5.
  Preparation
  of
  samples
  for
  phospholipid
  analysis
  and
  stable
isotope
  incubation
After
  overnight
  incubation,
  medium
  was
  removed
  and
  replaced
with
  X-vivo-15
  (Cambrex)
  supplemented
  with
  deuterated
  choline
(methyl-D9-choline,
  100
 g/ml,
  Sigma
  Aldrich),
  deuterated
  inositol
(myo-D6-inositol,
  100
 g/ml,
  C/D/N
  isotopes,
  Quebec)
  and
  deuter-
ated
  serine
  (serine-D3,
  100
 g/ml
  C/D/N
  isotopes),
  in
  the
  presence
or
  absence
  of
  HkEc
  (2.5:1).
Macrophages
  were
  incubated
  with
  the
  stable
  isotope-labelled
compounds
 for
 3
 h
 at
 37 ◦C
 in
 an
 atmosphere
 of
 5%
 (v/v)
 CO2.
 Subse-
quently,
  medium
  was
  removed
  and
  cells
  were
  washed
  with
  Hanks
Balanced
  Salt
  Solution
  (Invitrogen).
  The
  cells
  were
  lysed
  in
  1
 ml
ice-cold
  methanol
  for
  lipid
  extractions.
2.6.
  Phospholipid
  extraction
  and
  analysis
  by
  electrospray
ionisation
  mass
  spectrometry
Total
  lipid
  was
  extracted
  from
  macrophages
  using
  chloroform
and
  methanol
  as
  described
  previously
  (Bligh
  and
  Dyer,
  1959).
Samples
  were
  reconstituted
  in
  30
 l
  of
  a
  solution
  containing
  20%
butanol,
  60%
  methanol,
  16%
  water
  and
  4%
  concentrated
  aqueous
NH3 and
  introduced
  by
  direct
  infusion
  into
  a
  triple
  quadrupole
mass
 spectrometer
 (Quattro
 Ultima,
 Micromass,
 UK)
 equipped
 with
a
  nanoﬂow
  electrospray
  ionisation
  interface.
Phospholipid
  and
  neutral
  lipid
  species,
  both
  endogenous
  and
with
  incorporated
  stable
  isotope-labelled
  substrates,
  were
  selec-
tively
  detected
  and
  quantiﬁed
  from
  a
  variety
  of
  precursor
  (P)
  and
neutral
  loss
  (NL)
  scans.
  Phosphatidylcholine
  (PC)
  was
  analysed
  in
positive
  ionisation
  as
  P184+
  and
  P193+
  scans
  for
  endogenous
  and
newly
  synthesised
  (D9)
  PC.
  Phosphatidylinositol
  (PI)
  and
  phos-
phatidylserine
  (PS)
  were
  analysed
  in
  negative
  ionisation,
  as
  P241-
and
  P247-
  scans
  for
  endogenous
  PI
  and
  newly
  synthesised
  (D6)
  PI
respectively,
  and
  NL87-
  and
  NL90-
  for
  endogenous
  PS
  and
  newly
synthesised
  (D3)
  PS
  respectively.
  Data
  were
  processed
  using
  Mass-
Lynx
  software
  (Waters)
  and
  analysed
  using
  a
  custom-designed
macro
  (Postle
  et
  al.,
  2011).
  Correction
  for
  the 13C
  isotope
  was
performed
  prior
  to
  calculation
  of
  percentage
  composition
  and
incorporation
  of
  labelled
  phospholipid
  head
  groups.
  The
  fractional
incorporations
  of
  methyl-D9-choline,
  myo-D6-inositol
  and
  serine-
D3 into
  PC,
  PI
  and
  PS
  species
  respectively
  were
  calculated
  relative
to
  the
  total
  abundance.
  Only
  species
  of
  PC,
  PI
  and
  PS
  that
  consti-
tuted
  >2%
  of
  the
  total
  molar
  percentage
  of
  PC,
  PI
  or
  PS
  respectively
were
  considered
  quantiﬁable.
2.7.
  Shotgun
  lipidomics
  analysis
  of
  ileal
  biopsies
Shotgun
  lipidomics
  analysis
  was
  performed
  as
  described
previously
  (Han
  et
  al.,
  2004).
  Brieﬂy,
  samples
  were
homogenised
  in
  1
 ml
  ice-cold
  50
 mmol/l
  LiCl.
  Protein
  con-
tent
  was
  determined
  using
  the
  BCA
  assay.
  Internal
  standards,
including
  dimyristoylphosphatidylcholine
  (15
 nmol/mg
protein),
  dimyristoylphosphatidylserine
  (1
 nmol/mg
  pro-
tein),
  1,2-dipentadecanoyl-sn-glycero-3-phosphoglycerol
(4.2
 nmol/mg
  protein),
  1,2-dipentadecanoyl-sn-glycero-3-
phosphoethanolamine
  (18.75
 nmol/mg
  protein),
 17C18
  ceramide
(40
 pmol/mg
  protein)
  and
  triheptadecenoylglycerol
  (10
 nmol/mg
protein)
  were
  added
  and
  lipid
  extraction
  performed
  with
  a
  mod-
iﬁed
  Bligh
  and
  Dyer
  procedure.
  ESI-MS
  was
  performed
  using
a
  triple-quadrupole
  mass
  spectrometer
  (ThermoElectron
  TSQ
Quantum
  Ultra,
  San
  Jose,
  CA,
  USA)
  (Han
  et
  al.,
  2004).
2.8.
  Statistical
  analysis
Statistical
  analysis
  was
  determined
  using
  a
  paired
  or
  unpaired
student
 t-test
 in
 Microsoft
 Excel
 as
 appropriate.
 A
 p-value
 of
 p
 <
 0.05
was
  considered
  statistically
  signiﬁcant.
  For
  shotgun
  lipidomics
experiments,
  a
  threshold
  p-value
  of
  p
 <
 0.01
  was
  used.
3.
  Results
3.1.
  Sphingolipid
  composition
  of
  macrophages
  is
  altered
  after
stimulation
  with
  E.
  coli
  but
  does
  not
  differ
  between
  HC
  and
  CD
macrophages
The
  predominant
  ceramide
  species
  in
  both
  healthy
  control
  (HC)
and
  CD
  macrophages
  were
  the
  C16:0,
  C24:0
  and
  C24:1
  ceramides
(Fig.
  1A
  and
  B).
  There
  were
  no
  signiﬁcant
  differences
  in
  the
  mean
amounts
  of
  any
  ceramide
  species,
  dihydroceramide
  or
  sphingoid
base
  (Fig.
  1C
  and
  D)
  or
  total
  ceramide
  (Fig.
  1E)
  between
  HC
  (n
 =
 7)
and
  CD
  (n
 =
 8)
  macrophages
  in
  the
  unstimulated
  state.
Stimulation
  of
  HC
  macrophages
  with
  HkEc
  for
  4
 h
  resulted
  in
a
  signiﬁcant
  reduction
  in
  C16:0
  (p
 <
 0.05),
  C24:0
  (p
 <
 0.05)
  and
C24:1
  (p
 <
 0.01)
  ceramide
  species,
  and
  a
  signiﬁcant
  increase
  in
dihydrosphingosine
  (p
 <
 0.01)
  (Supplementary
  Fig.
  1).
  Similarly,
stimulation
  of
  CD
  macrophages
  with
  HkEc
  resulted
  in
  a
  signiﬁcant
reduction
  in
  C24:0
  (p
 <
 0.05)
  and
  C24:1
  (p
 <
 0.001)
  ceramides,
  with
a
  concomitant
  increase
  in
  dihydrosphingosine
  content
  (p
 <
 0.05)
(Supplementary
  Fig.
  1).
  There
  were
  no
  signiﬁcant
  differences
  in
the
  mean
  amounts
  of
  individual
  ceramide
  and
  dihydroceramide
species
  (Supplementary
  Fig.
  2A),
  sphingoid
  bases
  (Supplemen-
tary
  Fig.
  2B),
  and
  total
  ceramide
  content
  (Supplementary
  Fig.
  2C)
between
  HC
  and
  CD
  macrophages
  in
  the
  HkEc
  stimulated
  state.
3.2.
  Macrophage
  phosphatidylcholine
  composition
  and
  dynamics
alter
  following
  stimulation
  with
  E.
  coli,
  but
  are
  unchanged
  in
Crohn’s
  disease
Endogenous
  and
  newly
  synthesised
  PC
  species
  over
  a
  3
 h
  time
period
  were
  determined
  from
  precursor
  scans
  of
  m/z
  184+
  and
  m/z
193+
  respectively.
  Representative
  PC
  spectra
  generated
  as
  precur-
sor
  scans
  of
  m/z
  184+
  and
  193+
  are
  shown
  (Supplementary
  Fig.
  3A
and
  B).
  The
  predominant
  peaks
  at
  m/z
  760.8
  and
  786.8
  correspond1842 G.W.
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Fig.
  1.
  Ceramide
  and
  sphingoid
  base
  composition
  of
  CD
  macrophages
  is
  unaltered.
  The
  amounts
  of
  individual
  ceramide
  species
  were
  quantiﬁed
  in
  HC
  (n
 =
 7)
  and
  CD
  (n
 =
 8)
macrophages
  by
  HPLC-MS.
  (A
  and
  B)
  Pie
  charts
  depicting
  the
  proportion
  of
  various
  ceramides
  in
  HC
  and
  CD
  macrophages
  respectively,
  expressed
  as
  a
  percentage
  of
  the
  total
amount
  of
  ceramide
  detected.
  (C)
  The
  amounts
  of
  individual
  ceramide
  species
  (in
  pmol/mg
  protein)
  in
  unstimulated
  HC
  and
  CD
  macrophages.
  No
  signiﬁcant
  differences
  were
identiﬁed
  between
  HC
  and
  CD.
  (D)
  The
  amounts
  of
  sphingosine
  (Sph)
  and
  dihydrosphingosine
  (dhSph)
  in
  HC
  and
  CD
  macrophages.
  (E)
  Total
  amounts
  of
  ceramide
  in
  HC
  and
CD
  macrophages.
  Results
  are
  expressed
  as
  mean
 +
 SEM.
to
  endogenous
  PC
  16:0/18:1
  and
  PC
  18:0/18:2
  (or
  PC
  18:1/18:1)
species
  respectively.
  PC
  species
  newly
  synthesised
  over
  the
  three
hour
  time
  period
  can
  clearly
  be
  distinguished
  from
  endogenous
PC,
  using
  the
  m/z
  193+
  precursor
  scan.
  The
  peaks
  at
  m/z
  769.8
  and
m/z
  795.8
  correspond
  to
  newly
  synthesised
  PC
  16:0/18:1
  and
  PC
18:0/18:2
  species
  respectively.
In
  unstimulated
  HC
  (n
 =
 10)
  and
  CD
  (n
 =
 13)
  macrophages,
the
  predominant
  endogenous
  PC
  species
  were
  PC
  16:0/16:0,
  PC
16:0/18:1
  and
  PC
  18:0/18:2
  (Fig.
  2A).
  There
  were
  no
  signiﬁcant
  dif-
ferences
  in
  the
  molar
  percentage
  of
  any
  endogenous
  PC
  species
between
  HC
  and
  CD
  macrophages.
  Stimulation
  with
  HkEc
  caused
  a
reduction
  in
  the
  molar
  percentage
  of
  endogenous
  PC
  16:0/20:4
  in
HC
  (p
 <
 0.05)
  and
  CD
  (p
 <
 0.05)
  macrophages.
  No
  signiﬁcant
  differ-
ences
  were
  identiﬁed
  between
  CD
  and
  HC
  macrophages.
The
  proﬁle
  of
  newly
  synthesised
  PC
  species
  was
  similar
  to
that
  of
  the
  endogenous
  PC
  proﬁle
  of
  HC
  and
  CD
  macrophages.
PC
  16:0/18:1
  and
  PC16:0/18:2
  were
  the
  predominant
  newly-
synthesised
  species
  in
  HC
  and
  CD
  macrophages
  (Fig.
  2
  B).
Stimulation
  with
  HkEc
  increased
  the
  proportion
  of
  PC
  16:0/18:1
synthesised
  in
  HC
  macrophages,
  and
  increased
  the
  fraction
  of
synthesised
  PC
  16:0/16:1
  in
  CD
  cells.
  There
  were
  no
  signiﬁcant
  dif-
ferences
 in
 the
 molar
 percentage
 of
 any
 species
 between
 HC
 and
 CD
macrophages,
  either
  in
  the
  unstimulated
  state
  or
  after
  stimulation
with
  HkEc.
The
  incorporation
  of
  methyl-D9-choline
  into
  PC
  was
  also
  deter-
mined
  over
  3
 h
  in
  HC
  and
  CD
  macrophages,
  as
  a
  measure
  of
  the
global
  rate
  of
  synthesis
  of
  all
  PC
  species
  (Supplementary
  Fig.
  4).
The
  mean
  fractional
  incorporation
  of
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Fig.
  2.
  Composition
  of
  endogenous
  and
  newly
  synthesised
  PC
  in
  HC
  and
  CD
macrophages,
  in
  the
  presence
  and
  absence
  of
  HkEc.
  Composition
  of
  (A)
  endoge-
nous
  PC,
  consisting
  of
  various
  carbon
  chain
  length
  fatty
  acid
  species,
  and
  (B)
  newly
synthesised
  (D9)
  PC
  in
  unstimulated
  (HC
  n
 =
 10,
  CD
  n
 =
 13)
  and
  HkEc-stimulated
  (HC
n
 =
 7,
  CD
  n
 =
 8)
  macrophages,
  expressed
  as
  a
  molar
  percentage
  of
  total
  PC.
  Results
are
  mean
 +
 SEM.
  *
  indicates
  p
 <
 0.05.
thus
  rates
  of
  PC
  synthesis,
  were
  equivalent
  between
  HC
  and
  CD
cells.
  Stimulation
  with
  HkEc
  increased
  the
  mean
  fractional
  incor-
poration
 of
 methyl-D9-choline
 into
 PC
 in
 HC
 macrophages
 (p
 <
 0.01),
and
  CD
  macrophages
  (p
 <
 0.01)
  compared
  to
  unstimulated
  cells.
Stimulation
  was
  therefore
  associated
  with
  an
  increased
  rate
  of
PC
  synthesis;
  although
  no
  signiﬁcant
  differences
  were
  observed
between
  HC
  and
  CD
  macrophages.
3.3.
  Phosphatidylserine
  composition
  and
  dynamics
  do
  not
  differ
between
  HC
  and
  CD
  macrophages
Neutral
  loss
  scans
  of
  m/z
  87
  and
  m/z
  90
  were
  used
  to
  deter-
mine
  the
  proﬁle
  of
  endogenous
  and
  newly
  synthesised
  PS
  species
respectively
  in
  HC
  and
  CD
  macrophages.
  A
  representative
  neutral
loss
  scan
  of
  m/z
  87-
  is
  shown
  (Supplementary
  Fig.
  5A);
  the
  peak
at
  m/z
  788.9
  corresponding
  to
  the
  predominant
  endogenous
  PS
species
  (18:0/18:1).
  A
  representative
  neutral
  loss
  scan
  of
  m/z
  90-
is
  also
  shown
  (Supplementary
  Fig.
  5B);
  peaks
  at
  m/z
  763.8,
  789.9,
791.9
  and
  813.9
  correspond
  to
  the
  predominant
  newly
  synthesised
species
  PS
  16:0/18:1,
  PS
  18:0/18:2,
  PS
  18:0/18:1
  and
  PS
  18:0/20:4.
There
 were
 no
 signiﬁcant
 differences
 in
 the
 molar
 percentage
 of
 any
PS
 species
 between
 unstimulated
 HC
 and
 CD
 macrophages
 (Fig.
 3A).
There
  were
  no
  alterations
  in
  any
  endogenous
  PS
  species
  after
  stim-
ulation
  with
  HkEc,
  and
  no
  signiﬁcant
  differences
  between
  HC
  and
CD
  macrophages
  in
  the
  stimulated
  state.
The
  predominant
  newly
  synthesised
  PS
  species
  over
  the
  3
 h
time
  period
  in
  unstimulated
  HC
  and
  CD
  macrophages
  included
  PS
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Fig.
  3.
  Composition
  of
  endogenous
  and
  newly
  synthesised
  PS
  in
  HC
  and
  CD
macrophages,
  in
  the
  presence
  and
  absence
  of
  HkEc.
  Composition
  of
  (A)
  endoge-
nous
  PS
  and
  (B)
  synthesised
  (D3)
  PS,
  in
  unstimulated
  (HC
  n
 =
 7,
  CD
  n
 =
 9)
  and
HkEc-stimulated
  (HC
  n
 =
 6,
  CD
  n
 =
 5)
  macrophages.
  Results
  are
  expressed
  as
  a
  molar
percentage
  of
  total
  PS
  and
  are
  mean
 +
 SEM.
  No
  statistically
  signiﬁcant
  differences
were
  identiﬁed
  between
  HC
  and
  CD.
16:0/18:1,
  PS
  18:0/18:1,
  PS
  18:0/18:2
  and
  PS
  18:0/20:4
  species
(Fig.
  3B).
  No
  signiﬁcant
  differences
  were
  observed
  in
  the
  molar
percentage
  composition
  of
  any
  PS
  species
  between
  unstimulated
HC
  and
  CD
  macrophages.
  The
  proﬁles
  of
  the
  newly
  synthesised
PS
  species
  were
  comparable
  between
  unstimulated
  and
  HkEc-
stimulated
  macrophages,
  and
  similarly
  there
  were
  no
  differences
in
  the
  molar
  percentage
  of
  any
  PS
  species
  between
  HC
  and
  CD
macrophages.
  The
  rates
  of
  PS
  synthesis
  over
  3
 h
  were
  inferred
  from
the
  fractional
  incorporation
  of
  serine-D3 within
  the
  total
  PS
  (Sup-
plementary
  Fig.
  6).
  There
  were
  no
  differences
  between
  HC
  and
  CD
macrophages
  and,
  in
  contrast
  to
  PC,
  no
  alterations
  with
  HkEc
  stim-
ulation.
3.4.
  Analysis
  of
  PI
  in
  HC
  and
  CD
  macrophages
The
  composition
  of
  endogenous
  and
  newly
  synthesised
  PI
species
  was
  determined
  by
  precursor
  scans
  of
  m/z
  241-
  and
  m/z
247-
  respectively
  in
  HC
  and
  CD
  macrophages
  (Supplementary
Fig.
  7).
  The
  predominant
  endogenous
  PI
  species
  detected
  was
  PI
18:0/20:4,
 making
 up
 42.9
 ±
 2.7%
 and
 44.0
 ±
 1.8%
 of
 the
 total
 native
PI
  in
  HC
  and
  CD
  macrophages
  respectively.
  The
  endogenous
  PI
  pro-
ﬁles
  were
  equivalent
  between
  HC
  and
  CD
  macrophages,
  and
  the
composition
  was
  unaltered
  after
  HkEc
  stimulation
  (Fig.
  4A).
The
  proﬁle
  of
  newly
  synthesised
  PI
  species
  was
  strikingly
  dif-
ferent
  to
  that
  of
  endogenous
  PI,
  in
  both
  HC
  and
  CD
  macrophages1844 G.W.
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Fig.
  4.
  Composition
  of
  endogenous
  and
  newly
  synthesised
  PI
  in
  HC
  and
  CD
macrophages,
  in
  the
  presence
  and
  absence
  of
  HkEc.
  Composition
  of
  (A)
  endoge-
nous
  PI
  and
  (B)
  newly
  synthesised
  PI
  in
  unstimulated
  (HC
  n
 =
 7,
  CD
  n
 =
 9)
  and
HkEc-stimulated
  (HC
  n
 =
 6,
  CD
  n
 =
 5)
  macrophages.
  Results
  are
  expressed
  as
  a
  molar
percentage
  of
  the
  total
  PI
  and
  are
  mean
 +
 SEM.
  *
  indicates
  p
 <
 0.05.
(Fig.
  4B).
  In
  contrast
  to
  endogenous
  PI,
  no
  single
  species
  pre-
dominated;
  PI
  18:0/20:4
  accounted
  for
  only
  12.3
 ±
 1.1%
  of
  the
newly
  synthesised
  PI
  in
  HC
  macrophages
  and
  12.9
 ±
 1.8%
  in
  CD
macrophages.
  11
  additional
  species
  accounted
  for
  the
  remain-
ing
  newly
  synthesised
  PI.
  The
  proportion
  of
  newly
  synthesised
  PI
16:0/18:1
  was
  signiﬁcantly
  reduced
  in
  CD
  macrophages
  compared
to
  HC
  in
  the
  unstimulated
  state
  (p
 <
 0.05)
  (Fig.
  4B).
The
  fractional
  incorporation
  of
  myo-D6-inositol
  into
  total
  cellu-
lar
  PI
  was
  calculated
  as
  a
  measure
  for
  the
  global
  rate
  of
  PI
  synthesis
(Supplementary
  Fig.
  8).
  The
  mean
  fractional
  incorporation
  of
  myo-
D6-inositol
  as
  a
  percentage
  of
  the
  total
  PI
  was
  16.1
 ±
 2.3%
  in
  HC
  and
15.5
 ±
 1.5%
 in
 CD
 macrophages
 over
 3
 h,
 indicating
 equivalent
 over-
all
  rates
  of
  PI
  synthesis
  in
  HC
  and
  CD.
  In
  contrast
  to
  PC,
  there
  was
no
 alteration
 in
 the
 percentage
 incorporation
 after
 stimulation
 with
HkEc,
  indicating
  comparable
  rates
  of
  PI
  synthesis
  in
  unstimulated
and
  HkEc-stimulated
  macrophages.
3.5.
  Shotgun
  lipidomics
  analysis
  of
  ileal
  biopsies
Whilst
  the
  overall
  amounts
  of
  PC,
  PS,
  PG,
  phosphatidic
  acid
(PA),
  cardiolipin
  (CL),
  sphingolipids
  and
  cholesterol
  in
  the
  biopsy
samples
  did
  not
  differ
  between
  CD
  and
  HC
  (Fig.
  5A),
  a
  signiﬁcant
reduction
  in
  PI
  16:0/18:1
  (as
  a
  percentage
  of
  total
  PI)
  was
  observed
in
  CD
  compared
  to
  HC
  (p
 <
 0.01)
  (Fig.
  5B
  and
  C).
  This
  is
  the
  same
species
  that
  showed
  reduced
  synthesis
  in
  CD
  macrophages
  com-
pared
  to
  HC.
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Fig.
  5.
  Shotgun
  lipidomics
  analysis
  of
  ileal
  biopsies.
  (A)
  Total
  phospholipid
  (PC,
  PE,
CL,
  PG,
  PA,
  PS),
  sphingolipid
  (sphingomyelin,
  SM
  and
  ceramide,
  Cer)
  and
  cholesterol
(Chol)
  content
  did
  not
  differ
  between
  HC
  (n
 =
 5)
  and
  CD
  (n
 =
 5)
  patients.
  (B)
  Molar
percentage
 composition
 of
 phosphatidylinositol
 (PI)
 species.
 (C)
 Reduced
 molar
 per-
centage
  of
  PI
  16:0/18:1
  in
  CD
  biopsies
  compared
  to
  HC.
  **
  represents
  p
 <
 0.01.
4.
  Discussion
No
  gross
  abnormalities
  were
  identiﬁed
  in
  the
  endogenous
ceramide,
  dihydroceramide
  or
  sphingoid
  base
  composition
  of
  CD
macrophages,
  both
  in
  the
  unstimulated
  state
  and
  after
  stimula-
tion
  with
  HkEc.
  In
  addition,
  macrophage
  PC
  and
  PS
  composition,
and
  rates
  of
  PC
  and
  PS
  and
  PI
  synthesis,
  were
  unaltered
  in
CD
  macrophages;
  it
  is
  therefore
  unlikely
  that
  gross
  defects
  in
these
  lipids
  underlie
  the
  impaired
  cytokine
  release
  observed
  in
CD.
  Although
  previous
  studies
  have
  indicated
  differences
  in
  the
fatty
  acid
  proﬁles
  of
  plasma
  phospholipids
  (Geerling
  et
  al.,
  1999)
and
  PBMCs
  (Trebble
  et
  al.,
  2004)
  in
  CD
  patients,
  the
  inclusion
of
  patients
  with
  active
  disease
  raises
  the
  possibility
  that
  the
alterations
  observed
  could
  be
  a
  secondary
  phenomenon;
  indeed
studies
  investigating
  quiescent
  patients
  have
  yielded
  conﬂicting
results
  (Esteve-Comas
  et
  al.,
  1993).
  Secondly
  the
  speciﬁc
  proﬁles
of
  macrophage
  ceramides,
  PC,
  PS
  and
  PI
  were
  determined
  in
  this
study,
  whereas
  others
  have
  addressed
  fatty
  acid
  composition
  in
terms
  of
  the
  total
  percentage
  of
  fatty
  acids
  or
  phospholipid
  species.
In
  CD
  macrophages,
  the
  relative
  percentage
  of
  newly
  synthe-
sised
  PI
  16:0/18:1
  was
  reduced
  compared
  to
  HC,
  although
  this
  was
not
  associated
  with
  an
  alteration
  in
  either
  the
  overall
  rates
  of
  PI
synthesis
  or
  the
  molar
  percentage
  of
  endogenous
  PI
  16:0/18:1.
Importantly,
 shotgun
 lipidomic
 analysis
 of
 ileal
 biopsy
 samples
 also
revealed
  abnormalities
  in
  this
  PI
  species
  in
  CD,
  suggesting
  that
  the
observed
  reduction
  represents
  a
  genuine
  abnormality
  in
  CD.
  The
suggestion
  of
  an
  altered
  proﬁle
  of
  PI
  synthesis
  in
  CD
  patients
  is
intriguing
  as
  minor
  variations
  in
  PI
  content
  and
  composition
  canG.W.
  Sewell
  et
  al.
  /
  The
  International
  Journal
  of
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exert
 major
 effects
 on
 the
 physical
 properties
 of
 membrane
 systems
(Mulet
  et
  al.,
  2008).
  It
  is
  known
  that
  the
  p110
  isoform
  of
  PI
  3-
kinase,
  an
  enzyme
  involved
  in
  the
  generation
  of
  3-phosphorylated
phosphatidylinositol
  derivatives,
  is
  important
  in
  the
  TNF
  secretory
pathway
  (Low
  et
  al.,
  2010).
  It
  is
  therefore
  possible
  that
  altered
  PI
dynamics
  could
  contribute
  to
  the
  impairment
  in
  pro-inﬂammatory
cytokine
  secretion
  observed
  in
  CD.
We
 have
 developed
 a
 three-stage
 model
 for
 CD,
 in
 which
 the
 ﬁrst
stage
  is
  failure
  of
  intestinal
  barrier
  function
  followed
  by
  impaired
acute
  inﬂammation
  (Sewell
  et
  al.,
  2009).
  Phospholipids
  such
  as
  PI
are
  important
  components
  of
  intestinal
  mucus
  as
  well
  as
  cellular
components
  of
  the
  mucosa,
  and
  animal
  studies
  indicate
  a
  protec-
tive
  role
  for
  phospholipids
  in
  barrier
  function
  (Fabia
  et
  al.,
  1992).
It
  is
  plausible
  that
  abnormalities
  in
  the
  mucosal
  PI
  proﬁle
  could
alter
  membrane
  or
  mucus
  ﬂuidity,
  facilitating
  ingress
  of
  luminal
contents
  into
  the
  bowel
  wall
  directly;
  alternatively,
  such
  alter-
ations
  could
  enhance
  susceptibility
  to
  damaging
  emulsiﬁers
  such
as
  bile
  acids.
  Although
  alterations
  in
  the
  phospholipid
  composition
of
  intestinal
  mucus
  have
  previously
  been
  associated
  with
  ulcera-
tive
  colitis
  rather
  than
  CD
  (Braun
  et
  al.,
  2009),
  PI
  composition
  was
not
 determined
 in
 this
 study,
 which
 warrants
 further
 investigation.
The
  underlying
  mechanism
  of
  the
  reduced
  PI
  16:0/18:1
observed
  in
  CD
  can
  only
  be
  speculated
  on
  at
  this
  stage.
  Given
  that
the
  overall
  rate
  of
  PI
  synthesis
  is
  unchanged
  in
  CD
  macrophages,
the
  difference
  could
  relate
  to
  an
  altered
  substrate
  preference
  of
PI
  synthase
  in
  CD.
  Alternatively,
  abnormalities
  in
  the
  fatty
  acid
metabolism
  pathway
  could
  lead
  to
  altered
  fatty
  acid
  availability
  for
phospholipid
  synthesis.
  Notably,
  the
  recent
  GWAS
  meta-analysis
identiﬁed
  a
  CD-associated
  SNP
  in
  a
  region
  containing
  the
  FADS1
(Fatty
  acid
  desaturase
  1)
  gene
  (Franke
  et
  al.,
  2010).
  This
  association
adds
  credence
  to
  the
  hypothesis
  that
  fatty
  acid
  desaturation
  may
be
  relevant
  in
  the
  pathogenesis
  of
  CD.
Stimulation
  of
  macrophages
  with
  HkEc
  was
  associated
  with
alterations
  in
  ceramides
  and
  phospholipids,
  further
  implicating
roles
  for
  these
  lipids
  in
  inﬂammation
  and
  innate
  immunity.
  LPS,
TNF
  and
  IL-1
  were
  previously
  shown
  to
  cause
  a
  rapid
  increase
in
  the
  levels
  of
  ceramide
  in
  macrophage
  cell
  lines
  (MacKichan
  and
DeFranco,
  1999).
  In
  contrast
  with
  this
  previous
  work,
  HkEc
  stimu-
lation
  in
  the
  present
  study
  was
  associated
  with
  a
  reduction
  in
  the
C16:0,
  C24:0
  and
  C24:1
  ceramides,
  and
  a
  concomitant
  increase
  in
dihydrosphingosine
  content.
  This
  difference
  could
  relate
  to
  differ-
ential
  effects
  of
  speciﬁc
  Toll-like
  receptor
  and
  HkEc
  stimulation
  on
the
 sphingolipid
 pathway,
 or
 the
 different
 time
 frames
 investigated
in
  the
  two
  studies.
Alterations
 in
 the
 phospholipid
 proﬁle
 of
 macrophages
 observed
after
  stimulation
  with
  HkEc
  included
  a
  reduction
  in
  the
  amount
of
  endogenous
  PC
  16:0/20:4.
  Recent
  application
  of
  lipidomic
technologies
  to
  the
  activation
  of
  murine
  macrophages
  has
  demon-
strated
  rapid
  generation
  of
  a
  wide
  range
  of
  eicosanoids
  and
  other
oxylipins
 following
 mobilisation
 of
 arachidonate
 from
 major
 mem-
brane
  phospholipids,
  including
  PC
  and
  PS
  (Rouzer
  et
  al.,
  2007).
The
  decreased
  content
  of
  PC
  16:0/20:4
  in
  both
  control
  and
  CD
macrophages
  after
  E.
  coli
  activation
  is
  consistent
  with
  such
  arachi-
donate
  mobilisation.
  Intriguingly,
  the
  fractional
  synthesis
  of
  PC
16:0/20:4
  from
  D9-choline
  was
  unchanged
  in
  these
  activated
  cells,
even
  though
  the
  rate
  of
  total
  PC
  synthesis
  was
  increased,
  implying
there
  was
  no
  apparent
  deﬁcit
  of
  arachidonate
  availability
  for
  PC
synthesis
  under
  these
  conditions.
Comparison
 of
 patterns
 of
 D9-choline
 incorporation
 into
 PC
 with
the
  proﬁle
  of
  endogenous
  PC
  composition
  indicated
  a
  degree
  of
co-ordinated
  acyl
  remodelling,
  with
  enhanced
  initial
  synthesis
  of
all
  three
  18:2-containing
  species.
  Endogenous
  PC
  was
  relatively
enriched
  in
  disaturated
  and
  ether-linked
  PC
  species,
  which
  were
presumably
  all
  formed
  subsequently
  to
  initial
  PC
  synthesis
  de
  novo
by
  a
  variety
  of
  acyl
  exchange
  mechanisms.
  The
  extent
  of
  such
  acyl
remodelling
  was
  even
  more
  apparent
  for
  PS
  and
  PI
  synthesis.
  The
single
  species
  PS
  18:0/18:1
  accounted
  for
  over
  40%
  of
  the
  total
  PS,
but
  contributed
  less
  than
  20%
  of
  PS
  synthesised
  from
  serine-D3.
PS
  is
  formed
  by
  headgroup
  exchange
  from
  either
  PC
  or
  PE
  by
  the
action
  of
  PS
  synthase
  (Hermansson
  et
  al.,
  2011),
  but
  acyl
  exchange
mechanisms
  in
  PS
  synthesis
  have
  not
  been
  previously
  identiﬁed.
Similarly,
  PI
  18:0/20:4
  was
  >40%
  of
  total
  PI,
  but
  only
  12%
  of
  PI
synthesis
  from
  myo-D6-inositol,
  substantiating
  previous
  sugges-
tions
  that
  the
  high
  content
  of
  arachidonate
  in
  macrophage
  PI
  is
maintained
  not
  by
  its
  synthesis
  de
  novo
  from
  myo-inositol
  but
  by
direct
  acyl
  incorporation
  due
  to
  sequential
  activities
  of
  PLA2 and
acyltransferases
  enzymes,
  proposed
  from
  incorporation
  patterns
of
  D8-arachidonate
  (Balgoma
  et
  al.,
  2008).
Overall,
  in
  spite
  of
  the
  previous
  differences
  in
  cytokine
  release
and
  intestinal
  barrier
  function,
  no
  major
  differences
  in
  lipid
  com-
position
 and
 synthesis
 were
 observed
 between
 tissue
 samples
 from
CD
  patients
  and
  healthy
  controls,
  and
  their
  responses
  to
  bacte-
rial
  stimulation.
  In
  contrast
  to
  studies
  of
  elicited
  bone
  marrow
or
  peritoneal
  macrophages,
  all
  samples
  in
  our
  study
  were
  from
individual
  subjects,
  and
  inter-subject
  differences
  in
  lipid
  nutri-
tion
  could
  contribute
  to
  the
  variation
  in
  observed
  lipid
  responses.
Nevertheless,
  the
  results
  question
  the
  extent
  to
  which
  lipid
  mobili-
sation
 is
 obligatorily
 linked
 to
 macrophage
 activation,
 and
 suggest
 a
subtle
  difference
  in
  phosphatidylinositol
  composition
  in
  CD
  which
could
 have
 an
 important
 inﬂuence
 on
 cytokine
 release
 and
 mucosal
barrier
  function.
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